Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Researchers uncover lung adenocarcinoma’s early roots, tracing the cancer back to a specific cell type. These insights offer new hope for detection and prevention.
Finding the best antibodies for any application is usually a process of trial and error. An additional pre-screening step to predict which antibody pairs will be successful could speed up the search for an ideal match.
Using electromagnetic fields or implanted medical devices to stimulate the brain can have benefits, but also carries risks. Computer simulations that reflect the unique complexity of each patient can help predict and solve problems before they arise.
Managing diabetes is a daily burden for many. Through practical support, and funding of research and technology development, Diabetes Center Berne aims to lighten this load.
Set up originally to boost watchmaking, the Swiss Technology Innovation Centre, CSEM, in Neuchâtel now makes many other things tick, from spacecraft to solar power. Bahaa Roustom, vice president of marketing and business development, talks through four decades of innovation in service to industry, and highlights some of the biggest opportunities in technology on the horizon.
Targeting claudin-1 offers a promising approach for treating solid tumours by selectively killing cancer cells and breaking down barriers to immunotherapy.
Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.
Continuous, real-time monitoring of metabolic indicators could transform the way we track cultures of cells and organoids, with potential applications for regenerative medicine.
Unlike CAR-T-cell therapy, experimental CAR-NK treatments could potentially be used off-the-shelf against many cancers. But finding the right source of NK cells is vital.
Industry-wide collaborations are crucial for bringing exciting technologies such as AI radio access networks and uncrewed telecommunications aircraft to the real world.